Table 3. Patient characteristics after propensity score matching.
| Characteristics | Without endometriosis (n=41) | Arising from endometriosis (n=41) | p-value | |
|---|---|---|---|---|
| Age (yr) | 46.7±10.3 | 45.1±7.0 | 0.403 | |
| Histology | 0.752 | |||
| Clear cell | 20 (48.8) | 21 (51.2) | ||
| Endometrioid | 21 (51.2) | 20 (48.8) | ||
| FIGO stage | 0.896 | |||
| I | 29 (70.7) | 31 (75.6) | ||
| II | 7 (17.1) | 7 (17.1) | ||
| III | 3 (7.3) | 2 (4.9) | ||
| IV | 2 (4.9) | 1 (2.4) | ||
| Grade | 0.272 | |||
| 1 | 7 (17.1) | 13 (31.7) | ||
| 2 | 7 (17.1) | 9 (22.0) | ||
| 3 | 27 (65.8) | 19 (46.3) | ||
| Initial CA-125 (U/mL) | 367.7±745.9 | 307.1±588.4 | 0.684 | |
| Residual disease status after PDS | 0.222 | |||
| No residual disease | 40 (97.6) | 36 (87.8) | ||
| 0.1–1 cm residual disease | 1 (2.4) | 4 (9.8) | ||
| >1 cm residual disease | 0 | 1 (2.4) | ||
| LNM | >0.999 | |||
| Negative | 33 (80.5) | 34 (82.9) | ||
| Positive | 0 | 0 | ||
| Not done | 8 (19.5) | 7 (17.1) | ||
| ASA physical status | 0.179 | |||
| I | 15 (36.6) | 20 (48.8) | ||
| II | 12 (29.3) | 5 (12.2) | ||
| III | 1 (2.4) | 0 | ||
| unknown | 13 (31.7) | 16 (39.0) | ||
| Type of cytoreductive surgery | >0.999 | |||
| Complete staging | 40 (97.6) | 39 (95.1) | ||
| Fertility saving surgery | 1 (2.4) | 2 (4.9) | ||
| Surgical procedures before cytoreductive surgery | >0.999 | |||
| None | 35 (85.4) | 36 (87.8) | ||
| Unilateral oophorectomy | 5 (12.2) | 4 (9.8) | ||
| Unilateral ovarian cystectomy | 1 (2.4) | 1 (2.4) | ||
| No. of AC cycle | >0.999 | |||
| 4–6 | 30 (73.2) | 29 (70.7) | ||
| 1–3 | 4 (9.8) | 4 (9.8) | ||
| None | 7 (17.1) | 8 (19.5) | ||
| Platinum sensitivity | >0.999 | |||
| Resistant | 2 (4.9) | 1 (2.4) | ||
| Sensitive | 31 (75.6) | 32 (78.0) | ||
| Unknown | 8 (19.5) | 8 (19.5) | ||
Data are shown as mean±standard deviation or number (%).
AC, adjuvant chemotherapy; ASA, American Society of Anesthesiologist; CA, cancer antigen; FIGO, International Federation of Gynecology and Obstetrics; LNM, lymph node metastasis; PDS, primary debulking surgery.